Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
about
Comparative genomic analysis of pre-epidemic and epidemic Zika virus strains for virological factors potentially associated with the rapidly expanding epidemicPossible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisProduction of Japanese Encephalitis Virus Antigens in Plants Using Bamboo Mosaic Virus-Based VectorCross-reactivities between human IgMs and the four serotypes of dengue virus as probed with artificial homodimers of domain-III from the envelope proteins.Development of a blocking ELISA for detection of serum neutralizing antibodies against newly emerged duck Tembusu virus.Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infectionsYellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelersA Lentiviral Vector Expressing Japanese Encephalitis Virus-like Particles Elicits Broad Neutralizing Antibody Response in Pigs.Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris.A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses.Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in miceIn silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidateReceptors and routes of dengue virus entry into the host cells.Serologic survey of West Nile virus in horses from Central-West, Northeast and Southeast Brazil.Japanese encephalitis virus invasion of cell: allies and alleys.Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo.Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.A multiplex ELISA-based protein array for screening diagnostic antigens and diagnosis of Flaviviridae infection.A Saint Louis encephalitis and Rocio virus serosurvey in Brazilian horses.Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.West Nile virus: characterization and diagnostic applications of monoclonal antibodies.Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.A Novel Diagnostic Method to Detect Duck Tembusu Virus: A Colloidal Gold-Based Immunochromatographic Assay.Viral Determinants and Vector Competence of Zika Virus Transmission.Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of Incorporated into the TI-ComplexMolecular diagnosis of flaviviruses
P2860
Q23302003-2FC724FB-4C66-49FB-9EEF-09B370124101Q24289014-AB2252E4-9228-4269-A985-5363698D84B3Q27304342-8874AF93-990A-4F75-B806-D53DEFC208EAQ28804225-9BA5E07F-74B8-432F-A31E-B6ED013D7622Q33627913-69659831-C405-48A2-AFC7-9C50BCC7F1A0Q34354665-3E03765B-FF1F-4137-A54E-848C6CD183E5Q34541557-1145B441-F536-45DF-AD18-7BD56569C844Q34778121-EDFA11EA-C484-478F-BC5A-787FDFE27901Q35054744-2F33F5CF-30B4-4B7A-BEEC-DC931DE49960Q35175842-5101864D-206A-497E-A110-4C188DE863F5Q35799379-5B32BB4D-D2E0-4186-8BEF-3AD438EE4CB8Q35915029-17057A05-F2B1-4A20-9F3E-60321BBCC962Q36109311-26E4FE3B-B6AE-4B9E-980B-9AB85AE27A12Q36157927-6418655D-08C6-442D-A63A-ABDCF4324489Q38264828-907E331A-8E72-4D74-B0B8-2461B2CF7744Q38366005-DFC380A7-BB1B-4119-BEA0-DB77E4FCAAB0Q38567688-8A5D6514-21FA-4234-8F27-64FA83738F00Q38676634-84814D6E-FCC1-4748-9BFD-6EFF9C278824Q39039111-A67779FC-DD7E-436A-B4F2-BEDC82CC6E45Q39051535-B2153389-F976-4BCA-9B9A-75B0D39E747AQ39147168-8507BEA1-D2EF-49B0-BCDB-93DD32B563C2Q40164185-25D7CDE1-5A26-4995-8146-58AFACEBB724Q40190705-95C5F029-EA19-4444-B134-01A345D5E5DCQ40225317-A411DFD2-6044-4066-9724-F860432D7F94Q40290346-A757D70C-2AF9-4A34-AF73-4681802EADF6Q46261471-5AA2E92E-5A76-4F77-ACBB-A6475DBC9E89Q54962520-EFD65A3B-4366-4F6E-BAD6-B9764ED2EB0DQ55008804-AE290436-560F-4D21-9EC9-856513C85FD1Q55084391-95B99B70-49A4-4850-B0A8-07250811420EQ57063936-587E96AC-CC5D-4BBC-8D3D-5CF1699391CAQ58805838-3FDC54FC-EFC5-4275-8CC5-A06A66C23BFF
P2860
Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Domain III peptides from flavi ...... and targets for immunization.
@en
Domain III peptides from flavi ...... and targets for immunization.
@nl
type
label
Domain III peptides from flavi ...... and targets for immunization.
@en
Domain III peptides from flavi ...... and targets for immunization.
@nl
prefLabel
Domain III peptides from flavi ...... and targets for immunization.
@en
Domain III peptides from flavi ...... and targets for immunization.
@nl
P2093
P1433
P1476
Domain III peptides from flavi ...... and targets for immunization.
@en
P2093
Alberto Anastacio Amarilla
Jaqueline Raymondi Silva
Juliana Helena Chávez
Luiz Tadeu Moraes Figueiredo
P304
P356
10.1016/J.BIOLOGICALS.2010.07.004
P577
2010-11-01T00:00:00Z